BigHat Biosciences
EMPOWERING BIOLOGICS DEVELOPMENT WITH AI/ML

BigHat Biosciences is reimagining antibody discovery and engineering to create better antibodies faster and undertake novel designs far beyond what’s possible today.

Our antibody design platform integrates a high-speed antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties.

BigHat is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
 
BigHat operates out of San Carlos, CA in the San Francisco Bay Area. We pride ourselves on our team-oriented, inclusive, remote-friendly, and family-centric culture.

Supported by